Ovarian cancer urine test on horizon
This article was originally published in Clinica
A urine test that can detect ovarian cancer early could soon become a reality, claims Largo, Florida company GeoPharma. The firm has signed a pact with University of South Florida Research Foundations for the latter's diagnostic technology. The know-how could help the development of an easy-to-use, early test with a high level of reproducibility, claimed GeoPharma's president, Kotha Sekharam.
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.